Fresenius Medical Care is founded from a merger of Fresenius Worldwide Dialysis and National Medical Care. The company’s shares are listed at the stock exchanges in Frankfurt and New York.

The 100,000th^th dialysis machine comes off the production line. Fresenius Medical Cares’ ordinary share is admitted to the DAX, Germany’s blue-chip share index.

Fresenius Medical Care is the leading dialysis company caring for more than 119,000 patients in own dialysis centers worldwide. With a production output of more than 50 million dialyzers per year the company sets a new record.

The new dialysis therapy system 5008 is introduced in the market and wins the prize “Innovationspreis der Deutschen Wirtschaft”.

Fresenius Medical Care produces the 500,000th^th dialysis machine.

A new generation of home dialysis cyclers is launched – sleep•safe harmony – enabling most individualized treatment options with adapted APD (aAPD) therapy.

Launch of the 6008 CAREsystem, a new hemodialysis therapy system, that delivers advanced dialysis therapy more easily, leaving more time for direct patient care.

Fresenius Medical Care launches the 4008A dialysis machine tailored to needs in emerging markets.

By acquiring NxStage Medical, Inc., Fresenius Medical Care expands its product portfolio with an innovative technology for home dialysis offering patients greater flexibility.

Launch of the Global Sustainability Program that will enable us to step up our efforts to integrate sustainability into our business over the next years.

Production of the 2-billionth dialyzer – just seven years after the production of the 1-billionth.

Celebrating our 25th anniversary, as the world's leading provider of products and services for individuals with renal diseases.